It was later discovered that the p53 gene is frequently mutated in various cancers, leading to loss of heterozygoty, dysregulation of p53 feedback networks, and ultimately resulting in slower p53 turnover and thus accumulation of mutant p53 protein in tumor cells. Here, TP53 is linked to neoplasm.